2,4,5-Trifluorobenzoic acid

We are 2,4,5-Trifluorobenzoic acid CAS:446-17-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,4,5-Trifluorobenzoic acid
CAS.NO:446-17-3
Synonyms:2,4,5-Trifluorobenzoic acid
2,4,5-Trifluor-benzoesaeure
2,4,5-trifluorobenzenecarboxylic acid
2,4,5-trifluorobenzoate
Molecular Formula:C7H3F3O2
Molecular Weight:176.09300
 
Physical and Chemical Properties:
Density:1.536
Melting point:94-96ºC
Boiling point:241.9ºC
Flash point:100.1ºC
Index of Refraction:1.49
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pharmaceutical and liquid crystal material intermediates.

2,4,5-Trifluorobenzoic acid


Related News: The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.Clorhidrato de acetilidato de metilo CAS:14777-27-6 The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data./ Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.2-chloro-3-isothiocyanatoprop-1-ene CAS:14214-31-4 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.

Related Products
Product Name
2-Bromo-3-fluorotoluene View Details
Phenyltrimethoxysilane View Details
2,6-Difluoro-3-nitrobenzonitrile View Details
2,3,4,5,6-Pentafluorostyrene manufacturer N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide manufacturer 3-hydroxy-N-(4-methoxyphenyl)naphthalene-2-carboxamide manufacturer Copper Chloride Basic manufacturer Cylopropylmethyl chloride manufacturer